• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Heisenberg funding for Anne-Kathrin Classen

Bioengineer by Bioengineer
June 18, 2020
in Health
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Photo: Harlad Neumann

The German Research Foundation (DFG) is supporting Dr. Anne-Kathrin Classen with approximately 500,000 euros over five years, thereby honoring her research on the biological mechanisms that control the formation and healing of specialized tissues – so-called epithelia. As for example the skin, these tissues cover the surface of organisms. She was accepted into the Heisenberg program for this purpose. The DFG fellowship, named after Nobel Prize winner Werner Heisenberg in Physics, is awarded to researchers who fulfill all the requirements for appointment to a long-term professorship.

Classen has been doing research at the University of Freiburg since 2016 and is a member of the CIBSS and BIOSS clusters of excellence. She will take up the fellowship within the framework of the CIBSS – Centre for Integrative Biological Signalling Studies where she will investigate the collective behavior of cells in epithelia. “Wound healing and regeneration of such epithelia maintain their essential function as a protective barrier of the organism to the outside world,” explained Classen. She is investigating how cells in fruit flies use molecular signals to communicate with each other in order to repair tissue injuries. The researcher is particularly interested in the regulation of the cell cycle in this coordinated cell response and the role of metabolism. Classen is also interested in how cancer is fought in epithelial tissues. Cells in epithelia often divide, thereby fostering the frequent development of mutations in the genome and hence of cancer cells. It is not only the immune system that makes sure that these cells are discovered and destroyed: Epithelial cells can also recognize mutated neighboring cells and actively exclude them from the tissue. The question of how epithelial cells detect mutated neighboring cells is also part of Classen’s research project.

After completing her doctoral thesis at the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, she continued her research at the University of California in Berkley in the US and then founded her own research group in the DFG’s Emmy Noether Programme at the Ludwig-Maximilians-Universität in Munich and the University of Freiburg.

###

Further information on Anne Kathrin-Classen’s research:
http://www.bio.uni-freiburg.de/news/20190418-classen-en?set_language=en

For more information about the CIBSS cluster of excellence:
https://www.cibss.uni-freiburg.de/about/home/

Contact:

CIBSS – Centre for Integrative Biological Signalling Studies

Faculty of Biology

Media Contact
Dr. Anne-Kathrin Classen
[email protected]

Tags: BiologycancerCell Biology
Share12Tweet8Share2ShareShareShare2

Related Posts

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

February 7, 2026

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

February 7, 2026

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

February 7, 2026

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.